Macroautophagy and ERK phosphorylation counteract the antiproliferative effect of proteasome inhibitor in gastric cancer cells (vol 6, pg 228, 2010)

被引:0
作者
Wu, William Ka Kei
Cho, Chi Hin
Lee, Chung Wa
Wu, Ya Chun
Yu, Le
Li, Zhi Jie
Wong, Clover Ching Man
Li, Hai Tao
Zhang, Lin
Ren, Shun Xiang
Che, Chun Tao
Wu, Kaichun
Fan, Daiming
Yu, Jun
Sung, Joseph Jao Yiu
机构
关键词
D O I
10.1080/15548627.2021.1936778
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:709 / 709
页数:1
相关论文
共 50 条
  • [32] FV-429 induced apoptosis through ROS- mediated ERK2 nuclear translocation and p53 activation in gastric cancer cells (vol 116, pg 1624, 2015)
    Zhou, Y.
    Wei, L.
    Zhang, H.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (02) : 2050 - 2050
  • [33] LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells (vol 317, pg 24, 2012)
    Zhang, Jian
    Wang, Jian
    Guo, Qiqiang
    Wang, Yu
    Zhou, Ying
    Peng, Huizhi
    Cheng, Maosheng
    Zhao, Dongmei
    Li, Feng
    CANCER LETTERS, 2014, 349 (02) : 159 - 159
  • [34] RETRACTION: HDAC6 inhibitor TST strengthens the antiproliferative effects of PI3K/mTOR inhibitor BEZ235 in breast cancer cells via suppressing RTK activation (Retraction of Vol 9, art no 929, 2018)
    Sun, Shixiu
    Zhang, Yujie
    Zheng, Jianchao
    Duan, Biao
    Cui, Jie
    Chen, Yan
    Deng, Wenjie
    Ye, Bixing
    Liu, Lei
    Chen, Yongchang
    Du, Jun
    Gu, Luo
    CELL DEATH & DISEASE, 2019, 10 (9)
  • [35] RETRACTED: IN Vitro and In Vivo Interactions between the HDAC6 Inhibitor Ricolinostat (ACY1215) and the Irreversible Proteasome Inhibitor Carfilzomib in Non-Hodgkin Lymphoma Cells (Retracted article. See vol. 18, pg. 1181, 2019)
    Dasmahapatra, Girija
    Patel, Hiral
    Friedberg, Johnathan
    Quayle, Steven N.
    Jones, Simon S.
    Grant, Steven
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (12) : 2886 - 2897
  • [36] Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor a (ERa) in human cancer cells by inhibiting proteasome-dependent ERa degradation via association with Src (Withdrawal of Vol 285, Pg 21934, 2010)
    Liu, Haibo
    Qiu, Jianming
    Li, Nan
    Chen, Taoyong
    Cao, Xuetao
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296
  • [37] Cytotoxic effect of the bradykinin antagonist BKM570 in ovarian cancer cells: analysis of the molecular mechanisms of its anti-proliferative action (vol 277, pg 5146, 2010)
    Jutras, Stephanie
    Bachvarova, Magdalena
    Keita, Mamadou
    Bascands, Jean-Loup
    Mes-Masson, Anne-Marie
    Stewart, John M.
    Gera, Lajos
    Bachvarov, Dimcho
    FEBS JOURNAL, 2011, 278 (06) : 999 - 999
  • [38] The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression (vol 15, pg 719, 2024)
    Zhu, Q.
    Zhang, X.
    Zhang, L.
    Li, W.
    Wu, H.
    Yuan, X.
    Mao, F.
    Wang, M.
    Zhu, W.
    Qian, H.
    Xu, W.
    CELL DEATH & DISEASE, 2024, 15 (10):
  • [39] RETRACTION: SUMO-specific protease 6 promotes gastric cancer cells growth via de-SUMOylation of FoxM1 (Retraction of Vol 36, Pg 9865, 2015)
    Song, J. G.
    Xie, H. H.
    Li, N.
    TUMOR BIOLOGY, 2017,
  • [40] Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) rugs in human cancer cells (vol 216, pg 698, 2008)
    Cascone, Tina
    Morelli, Maria Pia
    Morgillo, Floriana
    Kim, Woo-Young
    Rodolico, Gabriella
    Pepe, Stefano
    Tortora, Giampaolo
    Berrino, Liberato
    Lee, Ho-Young
    Heymach, John V.
    Ciardiello, Fortunato
    JOURNAL OF CELLULAR PHYSIOLOGY, 2008, 217 (01) : 290 - 290